Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

U.S. Legislative Update: Takeaways for European Pharma (European Pharmaceutical Review)

Related Content

Four Steps to Maximize the Value of AI Innovation in Medtech

Five Steps Hotel Owners, Operators, and Management Companies Can Take to Mitigate Risk in the Face of Heightened Antitrust Scrutiny and a Wave of Lawsuits Involving Revenue-Management Tools

Life Sciences Licensing and M&A Update: Catching Up on Recent Decisions Affecting Commercially Reasonable Efforts Definitions and Post-Patent Expiration Royalty Obligations

The Rapid Rise of AI, in Five Charts

U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion

JAMS Release Mass Arbitration Procedures Following AAA’s Lead

Lawsuit Filed Challenging FDA Final Rule Regulating Laboratory Developed Tests

Delaware Supreme Court Holds That Boards Must Satisfy the MFW Framework in Controller Transactions to Obtain Business Judgment Deference (Westlaw Today)

Goodwin CLE Week 2025

Novo Holdings Completes $16.5 Billion Acquisition of Catalent

Goodwin Secures $452 Million Trade Secret Award for Insulet Corporation, One of The Largest Trade Secret Jury Awards in the Last Five Years

'Reverse Redlining' Suit Reveals Language Risks For Lenders (Law360)

Goodwin Welcomes Jacquelyn Burke to the Risk Management & Insurance Practice in Boston

AlloVir and Kalaris Therapeutics to Merge

Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas

Goodwin Becomes First Tenant at 3025 JFK, Settles in Ahead of Lateral Hiring Season (Philadelphia Business Journal)

Life Sciences

Litigation

Intellectual Property